| Literature DB >> 33039995 |
Mirjam Dieckelmann1, Juliana J Petersen1, Corina Güthlin1, Felix Reinhardt1, Jasper Plath1, Klaus Jeitler2,3, Thomas Semlitsch2, Ferdinand M Gerlach1, Andrea Siebenhofer4,3.
Abstract
OBJECTIVES: To review systematically the past 10 years of research activity into the healthcare experiences (HCX) of patients with chronic heart failure (CHF) in Germany, in order to identify research foci and gaps and make recommendations for future research.Entities:
Keywords: heart failure; international health services; quality in health care
Mesh:
Year: 2020 PMID: 33039995 PMCID: PMC7549456 DOI: 10.1136/bmjopen-2020-037158
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Study selection process. CHF, chronic heart failure.
Figure 2Number of times specific topics associated with healthcare experiences were described.
Study characteristics of included studies
| Study characteristics (n=18) | Number (%) |
| Year of publication | |
| 2008–2012 | 5 (28) |
| 2013–2018 | 13 (72) |
| Type of publication | |
| Journal article | 14 (78) |
| Doctoral thesis | 4 (22) |
| Study design | |
| RCT | 3 (17) |
| Longitudinal study | 6 (33) |
| Cross-sectional study | 5 (28) |
| Qualitative study | 4 (22) |
| Research area* | |
| Health services research | 8 (44) |
| Health education | 6 (33) |
| Psychosomatic medicine | 5 (28) |
| Geriatrics | 3 (17) |
| Family medicine | 3 (17) |
| Cardiac surgery | 3 (17) |
| Rehabilitation science | 3 (17) |
| Palliative medicine | 2 (11) |
| Pharmaceutical care | 2 (11) |
| Nursing | 1 (6) |
| Telemedicine | 1 (6) |
| Sample size | |
| 10<n≤ 25 | 3 (17) |
| 25<n≤100 | 10 (56) |
| 100<n<200 | 3 (17) |
| 200<n<500 | 2 (11) |
| Methods of assessment | |
| Interviews | 5 (28) |
| Survey | 12 (67) |
| Group discussion | 1 (6) |
| Method of evaluation | |
| Qualitative | 4 (22) |
| Quantitative | 12 (67) |
| Mixed | 2 (11) |
*Multiple selection possible.
RCT, randomised controlled trial.
Population characteristics of included studies
| Population characteristics (n=1868) | Outcome | Reported in n studies |
| Mean age | 67 years | 16 |
| Age range | 23–100 years | 6 |
| Sex (% female) | 31% | 18 |
| Ethnicity | – | 0 |
| Insurance status | – | 0 |
| Relationship status | 8 | |
| 64% | ||
| 36% | ||
| Housing situation | 6 | |
| 56% | ||
| 23% | ||
| 21% | ||
| Employment status | 6 | |
| 27% | ||
| 73% | ||
| Educational background | 6 | |
| 84% | ||
| 16% | ||
| Severity of symptoms | 15 | |
| 8% | ||
| 43% | ||
| 35% | ||
| 14% | ||
| Comorbidities, risk factors, state of mental health | Diverse | 10 |
| Type of heart failure | 8 | |
| Diverse | 3 | |
| HFrEF, HFpEF | 6 | |
| Global failure, left ventricular failure | 1 | |
| Therapeutic characteristics | Diverse | 16 |
HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; NYHA, New York Heart Association.
Figure 3Number of publications according to healthcare context and study design. CCT, clinically controlled trial; RCT, randomised controlled trial.